Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec;39(6):721-728.
doi: 10.1007/s13187-024-02456-3. Epub 2024 Jun 18.

One-Stop-Shop Cancer Screening Clinic: Acceptability Testing

Affiliations

One-Stop-Shop Cancer Screening Clinic: Acceptability Testing

Jeannie M Au et al. J Cancer Educ. 2024 Dec.

Abstract

Cancer screenings aid in the early detection of cancer and can help reduce cancer-related mortality. The current model of care for cancer screening is often siloed, based on the targeted cancer site. We tested the acceptability of a new model of care, called the One-Stop-Shop Cancer Screening Clinic, that centralizes cancer screenings and offers patients the option to complete all their recommended cancer screenings within one to two visits. We administered surveys to 59 community members and 26 healthcare providers to gather feedback about the One-Stop-Shop model of care. Both community members and providers identified potential benefits (e.g., decreased patient burden, increased completion of cancer screenings) and also potential challenges (e.g., challenges with workflow and timing of care) of the model of care. The results of the study support the acceptability of the model of care. Of the community members surveyed, 89.5% said, if offered, they would be interested in participating in the One-Stop-Shop Cancer Screening Clinic. Future studies are needed to formally evaluate the impact and cost effectiveness of the One-Stop-Shop Cancer Screening Clinic.

Keywords: Acceptability; Cancer screening; Early detection; System-level intervention.

PubMed Disclaimer

Conflict of interest statement

Declarations Ethics Approval The study was reviewed and deemed exempt human research by the Institutional Review Board of the Icahn School of Medicine at Mount Sinai (protocol code STUDY-21-01593). Competing Interests The authors declare no competing interests.

References

    1. Heron M, Anderson RN (2016) Changes in the leading cause of death: recent patterns in Heart Disease and Cancer Mortality. NCHS Data Brief 254:1–8
    1. Zavala VA, Bracci PM, Carethers JM, Carvajal-Carmona L, Coggins NB, Cruz-Correa MR, Davis M, de Smith AJ, Dutil J, Figueiredo JC, Fox R, Graves KD, Gomez SL, Llera A, Neuhausen SL, Newman L, Nguyen T, Palmer JR, Palmer NR, Perez-Stable EJ, Piawah S, Rodriquez EJ, Sanabria-Salas MC, Schmit SL, Serrano-Gomez SJ, Stern MC, Weitzel J, Yang JJ, Zabaleta J, Ziv E, Fejerman L (2021) Cancer health disparities in racial/ethnic minorities in the United States. Br J Cancer 124(2):315–332. https://doi.org/10.1038/s41416-020-01038-6 - DOI - PubMed
    1. Loud JT, Murphy J (2017) Cancer screening and early detection in the 21(St) Century. Semin Oncol Nurs 33(2):121–128. https://doi.org/10.1016/j.soncn.2017.02.002 - DOI - PubMed - PMC
    1. Pace LE, Keating NL (2014) A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA 311(13):1327–1335. https://doi.org/10.1001/jama.2014.1398 - DOI - PubMed
    1. Force USPSTA, Recommendations B. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topi... . Accessed 28 May 2024

LinkOut - more resources